Human medicine: approvals, safety communications and the trials and disclosures behind them.
SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: INCY), to commercialise, distribute, and register...
Aktuelle HRX-Daten treiben den „Instantaneous Ablation"-Arbeitsablauf von Field Medical voran und erweitern die klinische Evidenz für Hochvolt-Fokal-PFA mit dem FieldForce™-PFA-System. ATLANTA und CARLSBAD, Kalifornien, 20. September 2026 /PRNewswire/ -- Field Medical, Inc., ein...
Les données de dernière minute présentées à HRX font progresser le protocole d'« ablation instantanée » de Field Medical et étoffent les données cliniques sur l'ablation focale par champ pulsé (PFA) à haute tension avec le système de PFA FieldForce™ ATLANTA et CARLSBAD, Californie, 20...
Confirmed rules and announcements from government bodies, regulators and official journals.
Negotiations are progressing on a global framework for pathogen access and benefit-sharing ahead of a UN General Assembly meeting. This will impact future research, development, and equitable distribution of medical countermeasures.
The EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Adcomfo (omalizumab). This indicates a step closer to approval for a new human medicine, potentially expanding treatment options.
Japan's MHLW has selected priority areas for regional medical and nursing care reform. This aims to strengthen local healthcare systems and ensure comprehensive services.
This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.
Read it in full for $29No app-store installation. Cancel any time.
Every item links to the institution that published it. Nothing is rewritten without its source.
